BRONCHO SALINE Drug Patent Profile
✉ Email this page to a colleague
When do Broncho Saline patents expire, and when can generic versions of Broncho Saline launch?
Broncho Saline is a drug marketed by Blairex and is included in one NDA.
The generic ingredient in BRONCHO SALINE is sodium chloride. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BRONCHO SALINE?
- What are the global sales for BRONCHO SALINE?
- What is Average Wholesale Price for BRONCHO SALINE?
Summary for BRONCHO SALINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 328 |
| Clinical Trials: | 39 |
| Patent Applications: | 2,433 |
| DailyMed Link: | BRONCHO SALINE at DailyMed |
Recent Clinical Trials for BRONCHO SALINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| OM Pharma | Phase 4 |
| People's Hospital of Anshun City of Guizhou Province | Phase 2/Phase 3 |
| Sandoz | Phase 3 |
US Patents and Regulatory Information for BRONCHO SALINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blairex | BRONCHO SALINE | sodium chloride | AEROSOL, METERED;INHALATION | 019912-001 | Sep 3, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
